COVID-19-Associated Invasive Pulmonary Aspergillosis in the Intensive Care Unit: A Case Series in a Portuguese Hospital

被引:6
作者
Ranhel, David [1 ]
Ribeiro, Ana [1 ]
Batista, Judite [1 ]
Pessanha, Maria [1 ]
Cristovam, Elisabete [1 ]
Duarte, Ana [1 ]
Dias, Ana [1 ]
Coelho, Luis [1 ]
Monteiro, Filipa [1 ]
Freire, Pedro [1 ]
Verissimo, Cristina [2 ]
Sabino, Raquel [2 ,3 ]
Toscano, Cristina [1 ]
机构
[1] Ctr Hosp Lisboa Ocidental, P-1349019 Lisbon, Portugal
[2] Natl Hlth Inst Dr Ricardo Jorge, Infect Dis Dept, P-1649016 Lisbon, Portugal
[3] Univ Lisbon, Fac Med, Inst Saude Ambiental, P-1649028 Lisbon, Portugal
关键词
COVID-19; intensive care unit; Aspergillus; invasive pulmonary aspergillosis; COVID-19-associated invasive pulmonary aspergillosis; COVID-19;
D O I
10.3390/jof7100881
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Invasive pulmonary aspergillosis (IPA) has become a recognizable complication in coronavirus disease 2019 (COVID-19) patients admitted to intensive care units (ICUs). Alveolar damage in the context of acute respiratory distress syndrome (ARDS) appears to be the culprit in facilitating fungal invasion in COVID-19 patients, leading to a COVID-19-associated pulmonary aspergillosis (CAPA) phenomenon. From November 2020 to 15 February 2021, 248 COVID-19 patients were admitted to our ICUs, of whom ten patients (4% incidence) were classified as either probable (six) or possible (four) CAPA cases. Seven patients had positive cultural results: Aspergillus fumigatus sensu stricto (five), A. terreus sensu stricto (one), and A. welwitschiae (one). Five patients had positive bronchoalveolar lavage (BAL) and galactomannan (GM), and two patients had both positive cultural and GM criteria. All but two patients received voriconazole. Mortality rate was 30%. Strict interpretation of classic IPA definition would have resulted in eight overlooked CAPA cases. Broader diagnostic criteria are essential in this context, even though differentiation between Aspergillus colonization and invasive disease might be more challenging. Herein, we aim to raise awareness of CAPA in view of its potential detrimental outcome, emphasizing the relevance of a low threshold for screening and early antifungal treatment in ARDS patients.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] COVID-19-Associated Mucormycosis in a Tertiary Care Hospital in India: A Case Series
    Singh, Shivam
    Basera, Pragati
    Anand, Aditya
    Ozair, Ahmad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [22] Covid-19-Associated Pulmonary Aspergillosis: The Other Side of the Coin
    Costantini, Claudio
    van de Veerdonk, Frank L.
    Romani, Luigina
    VACCINES, 2020, 8 (04) : 1 - 9
  • [23] COVID-19-associated pulmonary aspergillosis: an underdiagnosed or overtreated infection?
    Rouze, Anahita
    Martin-Loeches, Ignacio
    Nseir, Saad
    CURRENT OPINION IN CRITICAL CARE, 2022, 28 (05) : 470 - 479
  • [24] COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave
    Bretagne, Stephane
    Sitbon, Karine
    Botterel, Francoise
    Delliere, Sarah
    Letscher-Bru, Valerie
    Chouaki, Taieb
    Bellanger, Anne-Pauline
    Bonnal, Christine
    Fekkar, Arnault
    Persat, Florence
    Costa, Damien
    Bourgeois, Nathalie
    Dalle, Frederic
    Lussac-Sorton, Florian
    Paugam, Andre
    Cassaing, Sophie
    Hasseine, Lilia
    Huguenin, Antoine
    Guennouni, Nadia
    Mazars, Edith
    Le Gal, Solene
    Sasso, Milene
    Brun, Sophie
    Cadot, Lucile
    Cassagne, Carole
    Cateau, Estelle
    Gangneux, Jean-Pierre
    Moniot, Maxime
    Roux, Anne-Laure
    Tournus, Celine
    Desbois-Nogard, Nicole
    Le Coustumier, Alain
    Moquet, Olivier
    Alanio, Alexandre
    Dromer, Francoise
    MICROBIOLOGY SPECTRUM, 2021, 9 (02):
  • [25] COVID-19-associated pulmonary aspergillosis in critically ill patients: experience of a Chilean public hospital
    Araya Rojas, Fernando
    Lasso Barreto, Martin
    REVISTA CHILENA DE INFECTOLOGIA, 2021, 38 (05): : 754 - 760
  • [26] COVID-19-associated pulmonary aspergillosis in a tertiary care center in Shenzhen City
    Jiang, Zhaofang
    Chen, Shuyan
    Zhu, Qing
    Xiao, Yanyu
    Qu, Jiuxin
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2022, 15 (02) : 222 - 227
  • [27] Tracheal Aspirate Galactomannan Testing in COVID-19-Associated Pulmonary Aspergillosis
    Roman-Montes, Carla M.
    Bojorges-Aguilar, Saul
    Diaz-Lomeli, Paulette
    Cervantes-Sanchez, Axel
    Rangel-Cordero, Andrea
    Martinez-Gamboa, Areli
    Sifuentes-Osornio, Jose
    Ponce-de-Leon, Alfredo
    Gonzalez-Lara, Maria F.
    FRONTIERS IN FUNGAL BIOLOGY, 2022, 3
  • [28] Comparison of influenza- and COVID-19-associated pulmonary aspergillosis in China
    Jiankang Zhao
    Xianxia Zhuo
    Danni Pu
    Guohui Fan
    Binghuai Lu
    Bin Cao
    European Journal of Clinical Microbiology & Infectious Diseases, 2024, 43 : 683 - 692
  • [29] Comparison of influenza- and COVID-19-associated pulmonary aspergillosis in China
    Zhao, Jiankang
    Zhuo, Xianxia
    Pu, Danni
    Fan, Guohui
    Lu, Binghuai
    Cao, Bin
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2024, 43 (04) : 683 - 692
  • [30] A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA)
    Feys, Simon
    Almyroudi, Maria Panagiota
    Braspenning, Reinout
    Lagrou, Katrien
    Spriet, Isabel
    Dimopoulos, George
    Wauters, Joost
    JOURNAL OF FUNGI, 2021, 7 (12)